Tag: Pharmacy Australia Centre of Excellence

PreveCeutical Announces Successful Completion from its Design, Synthesis and Preliminary Evaluation of Novel Designed Peptides Derived from Caribbean Blue Scorpion Venom in a Cell-Based Brain Cancer Model

PreveCeutical Medical Inc. (CSE:PREV,  OTCQB:PRVCF, FSE:18H) (the “Company” or “PreveCeutical”), is pleased to announce the successful completion of the design, synthesis and...

PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund

PreveCeutical Medical Inc. is pleased to announce that it has received a cash refund of $616,802 AUD from the Australian...

PreveCeutical Announces the Successful Engineering & Cell-Based Efficacy Screening of its Smart-siRNA Constructs for its Dual Gene Therapy Research Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB: PRVCF, FSE:18H), is pleased to provide an update on its dual gene therapy program.